Literature DB >> 8898989

Role of increased DNA replication in the carcinogenic risk of nonmutagenic chemical carcinogens.

M L Cunningham1.   

Abstract

DNA replication is not an error-free process; therefore induction of cell proliferation with the requisite increase in DNA replication may be an important mechanism by which carcinogenesis can be induced by chemicals. Data presented in this overview indicate a positive association between increased cell proliferation and carcinogenesis, and illustrate the value of performing mechanistic studies such as cell proliferation assays in conjunction with short-term tests to further investigate the results of cancer bioassays. Whereas chemically-induced cell proliferation per se may not be sufficient to induce carcinogenesis, it creates a favorable environment for tumor development. There are two types of chemically-induced cell proliferation, mitogenic and cytotoxic, and they have different consequences regarding the mechanism of carcinogenesis of a chemical. Mitogenic chemical such as phenobarbital, oxazepam, and the peroxisome proliferating agents exert a short-term cell proliferative response that may exert its primary effect in carcinogenesis at the promotion stages. It is not clear at what stage(s) cytotoxic agents such as methapyrilene, alpha 2u-globulin inducers or saccharin exert their effects in carcinogenesis. A confounding factor in evaluation of cell proliferation in risk assessments is the production of chemical specific pleiotropic effects that may contribute to the carcinogenicity of a chemical. It is clear that mechanistic studies performed to understand the relationship of sex, species and dose in rodent carcinogenicity assays of chemicals is critical for the extrapolation of such data for human health assessments.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8898989     DOI: 10.1016/s0165-1110(96)90012-3

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  6 in total

1.  A mouse model of hepatocellular carcinoma: ectopic expression of fibroblast growth factor 19 in skeletal muscle of transgenic mice.

Authors:  Katrina Nicholes; Susan Guillet; Elizabeth Tomlinson; Kenneth Hillan; Barbara Wright; Gretchen D Frantz; Thinh A Pham; Lisa Dillard-Telm; Siao Ping Tsai; Jean-Philippe Stephan; Jeremy Stinson; Timothy Stewart; Dorothy M French
Journal:  Am J Pathol       Date:  2002-06       Impact factor: 4.307

2.  Hepatocellular carcinomas in B6C3F1 mice treated with Ginkgo biloba extract for two years differ from spontaneous liver tumors in cancer gene mutations and genomic pathways.

Authors:  Mark J Hoenerhoff; Arun R Pandiri; Stephanie A Snyder; Hue-Hua L Hong; Thai-Vu Ton; Shyamal Peddada; Keith Shockley; Kristine Witt; Po Chan; Cynthia Rider; Linda Kooistra; Abraham Nyska; Robert C Sills
Journal:  Toxicol Pathol       Date:  2012-12-21       Impact factor: 1.902

Review 3.  The traditional toxicologic paradigm is correct: dose influences mechanism.

Authors:  J I Goodman
Journal:  Environ Health Perspect       Date:  1998-02       Impact factor: 9.031

Review 4.  The H19 Long non-coding RNA in cancer initiation, progression and metastasis - a proposed unifying theory.

Authors:  Eli Raveh; Imad J Matouk; Michal Gilon; Abraham Hochberg
Journal:  Mol Cancer       Date:  2015-11-04       Impact factor: 27.401

5.  Computational modeling identifies key gene regulatory interactions underlying phenobarbital-mediated tumor promotion.

Authors:  Raphaëlle Luisier; Elif B Unterberger; Jay I Goodman; Michael Schwarz; Jonathan Moggs; Rémi Terranova; Erik van Nimwegen
Journal:  Nucleic Acids Res       Date:  2014-01-23       Impact factor: 16.971

Review 6.  Correct Identification of Cell of Origin May Explain Many Aspects of Cancer: The Role of Neuroendocrine Cells as Exemplified from the Stomach.

Authors:  Helge Waldum; Patricia G Mjønes
Journal:  Int J Mol Sci       Date:  2020-08-11       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.